{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:24:17Z","timestamp":1787628257170,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bbrc.2025.151680","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T03:00:24Z","timestamp":1742698824000},"page":"151680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel potent heterocyclic Grb2\u2013SH2 domain antagonists as potential anti-proliferative agents"],"prefix":"10.1016","volume":"760","author":[{"given":"Vasundhara","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-9892","authenticated-orcid":false,"given":"Yatender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-4240","authenticated-orcid":false,"given":"Sonika","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bbrc.2025.151680_bib1","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1074\/jbc.274.21.14956","article-title":"Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells","volume":"274","author":"Ward","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bbrc.2025.151680_bib2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1158\/1535-7163.1289.3.10","article-title":"Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain binding antagonists","volume":"3","author":"Soriano","year":"2004","journal-title":"Mol. Cancer Therapeut."},{"issue":"7","key":"10.1016\/j.bbrc.2025.151680_bib3","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.4049\/jimmunol.1501764","article-title":"Grb2 is important for T cell development, Th cell differentiation, and induction of experimental autoimmune encephalomyelitis","volume":"196","author":"Radtke","year":"2016","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bbrc.2025.151680_bib4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00432-009-0574-8","article-title":"Overexpression of Grb2\/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance","volume":"135","author":"Yu","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bbrc.2025.151680_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085170","article-title":"Identification of GRB2 and GAB1 coexpression as an unfavorable prognostic factor for hepatocellular carcinoma by a combination of expression profile and network analysis","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bbrc.2025.151680_bib6","first-page":"3135","article-title":"Expression pattern of FGFR2, Grb2 and Plc\u03b31 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma","volume":"5","author":"Timsah","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbrc.2025.151680_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/15216540050033195","article-title":"Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines","volume":"49","author":"Watanabe","year":"2000","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.bbrc.2025.151680_bib8","article-title":"Oncogenic role of Grb2 in breast cancer and Grb2 antagonists as therapeutic drugs","volume":"3","author":"Wang","year":"2017","journal-title":"Cancer Ther. Oncol. Int. J."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151680_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/10799893.2016.1155067","article-title":"Structural basis of focal adhesion targeting domain-mediated signaling in cardiac hypertrophy","volume":"37","author":"Mohanty","year":"2017","journal-title":"J. Recept. Signal Transduction"},{"issue":"249","key":"10.1016\/j.bbrc.2025.151680_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003576","article-title":"Grb2, a double-edged sword of receptor tyrosine kinase signaling","volume":"5","author":"Belov","year":"2012","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151680_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ceb.2007.02.013","article-title":"Dynamic control of signaling by modular adaptor proteins","volume":"19","author":"Pawson","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151680_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.cad.0000185180.72604.ac","article-title":"Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy","volume":"17","author":"Dharmawardana","year":"2006","journal-title":"Anti Cancer Drugs"},{"issue":"1","key":"10.1016\/j.bbrc.2025.151680_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-11876-9","article-title":"MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells","volume":"7","author":"Beigbeder","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbrc.2025.151680_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236839","article-title":"NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation","volume":"15","author":"Lewis","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbrc.2025.151680_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.09.001","article-title":"Nuclear FAK controls chemokine transcription, tregs, and evasion of anti-tumor immunity","volume":"163","author":"Serrels","year":"2015","journal-title":"Cell"},{"issue":"Pt 3","key":"10.1016\/j.bbrc.2025.151680_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj20020065","article-title":"Characterization of an activated mutant of focal adhesion kinase: \u2018SuperFAK","volume":"365","author":"Gabarra-Niecko","year":"2002","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151680_bib17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbrc.2010.07.066","article-title":"Fusion protein based on Grb2-SH2 domain for cancer therapy","volume":"399","author":"Saito","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bbrc.2025.151680_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1172\/JCI16290","article-title":"The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis","volume":"111","author":"Zhang","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.151680_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jmgm.2017.12.008","article-title":"Structure of focal adhesion kinase in healthy heart versus pathological cardiac hypertrophy: a modeling and simulation study","volume":"80","author":"Mohanty","year":"2018","journal-title":"J. Mol. Graph. Model."},{"issue":"6508","key":"10.1016\/j.bbrc.2025.151680_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/372786a0","article-title":"Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase","volume":"372","author":"Schlaepfer","year":"1994","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.bbrc.2025.151680_bib21","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1021\/jm980159a","article-title":"Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain","volume":"41","author":"Furet","year":"1998","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151680_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/jm980388x","article-title":"Potent inhibition of Grb2 SH2 domain binding by non-phosphate- containing ligands","volume":"42","author":"Yao","year":"1999","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bbrc.2025.151680_bib23","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1016\/S0960-894X(98)00513-7","article-title":"Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain","volume":"8","author":"Schoepfer","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.bbrc.2025.151680_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0960-894X(98)00740-9","article-title":"Monocarboxylic-based phosphotyrosyl mimetics in the design of Grb2 SH2 domain inhibitors","volume":"9","author":"Burke","year":"1999","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"16","key":"10.1016\/j.bbrc.2025.151680_bib25","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0960-894X(98)00376-X","article-title":"Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT)","volume":"8","author":"Roller","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"July","key":"10.1016\/j.bbrc.2025.151680_bib26","article-title":"Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain","volume":"51","author":"Xiao","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"20","key":"10.1016\/j.bbrc.2025.151680_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115711","article-title":"Rational design of cell-permeable cyclic peptides containing a D-Pro-L-Pro motif","volume":"28","author":"Wen","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.bbrc.2025.151680_bib28","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0960-894X(99)00299-1","article-title":"Structure-based design of a non-peptidic antagonist of the SH2 domain of Grb2","volume":"9","author":"Caravatti","year":"1999","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"18","key":"10.1016\/j.bbrc.2025.151680_bib29","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2174\/1381612003398546","article-title":"Structure-based design of compounds inhibiting grb2-SH2 mediated protein-protein interactions in signal transduction pathways","volume":"6","author":"Fretz","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151680_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<235::AID-IJC15>3.0.CO;2-B","article-title":"Selective Grb2 SH2 inhibitors as anti-Ras therapy","volume":"83","author":"Gay","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbrc.2025.151680_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/adt.2018.887","article-title":"\u201cIn silico screening to identify inhibitors of growth factor receptor 2-focal adhesion kinase interaction for therapeutic treatment of pathological cardiac hypertrophy,\u201d","volume":"17","author":"Mohanty","year":"2019","journal-title":"Assay Drug Dev. Technol."},{"issue":"33","key":"10.1016\/j.bbrc.2025.151680_bib32","first-page":"1","article-title":"Open Babel","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"10","key":"10.1016\/j.bbrc.2025.151680_bib33","first-page":"1","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"8","key":"10.1016\/j.bbrc.2025.151680_bib34","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151680_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200188","article-title":"Speed vs accuracy: effect on ligand pose accuracy of varying box size and exhaustiveness in AutoDock Vina","volume":"42","author":"Agarwal","year":"2023","journal-title":"Mol. Inform."},{"issue":"7","key":"10.1016\/j.bbrc.2025.151680_bib36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nsb0796-586","article-title":"Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode","volume":"3","author":"Rahuel","year":"1996","journal-title":"Nat. Struct. Biol."},{"issue":"January","key":"10.1016\/j.bbrc.2025.151680_bib37","first-page":"1","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbrc.2025.151680_bib38","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151680_bib39","author":"Case Ross C Walker"},{"issue":"1","key":"10.1016\/j.bbrc.2025.151680_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"Ff19SB: amino-acid-specific protein backbone parameters trained against quantum Mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theor. Comput."},{"issue":"9","key":"10.1016\/j.bbrc.2025.151680_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"20035_Ftp","volume":"56531","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151680_bib42","first-page":"U403","article-title":"Antechamber, an accessory software package for molecular mechanical calculations","volume":"222","author":"Wang","year":"2001","journal-title":"J. Am. Chem. Soc."},{"issue":"43","key":"10.1016\/j.bbrc.2025.151680_bib43","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A"},{"issue":"9","key":"10.1016\/j.bbrc.2025.151680_bib44","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"issue":"SUPPL","key":"10.1016\/j.bbrc.2025.151680_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151680_bib46","first-page":"21","article-title":"HHS public access","volume":"16","author":"Prasanna","year":"2020"},{"issue":"4","key":"10.1016\/j.bbrc.2025.151680_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cbpa.2006.06.015","article-title":"Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery","volume":"10","author":"Varma","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151680_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.151680_bib49","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ejmech.2014.12.006","article-title":"European Journal of Medicinal Chemistry Decision trees to characterise the roles of permeability and solubility on the prediction of oral absorption","volume":"90","author":"Newby","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"June","key":"10.1016\/j.bbrc.2025.151680_bib50","article-title":"Heliyon QSAR , molecular docking and ADMET properties in silico studies of novel as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase","volume":"7","author":"Daoui","year":"2021","journal-title":"Heliyon"},{"issue":"50","key":"10.1016\/j.bbrc.2025.151680_bib51","doi-asserted-by":"crossref","first-page":"31653","DOI":"10.1016\/S0021-9258(18)31745-9","article-title":"Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2","volume":"269","author":"Lemmon","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151680_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229659","article-title":"A convenient renewable surface plasmon resonance chip for relative quantification of genetically modified soybean in food and feed","volume":"15","author":"Pl\u00e1cido","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151680_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/BS.S85537","article-title":"Label-free interaction analysis as a tool to demonstrate biosimilarity of therapeutic monoclonal antibodies","volume":"5","author":"Sinha-Datta","year":"2015","journal-title":"Biosimilars"},{"key":"10.1016\/j.bbrc.2025.151680_bib54","series-title":"Title : Kinetics and Affinity Evaluation of Monoclonal Antibodies and","first-page":"1","author":"Fortebio","year":"2021"},{"key":"10.1016\/j.bbrc.2025.151680_bib55","doi-asserted-by":"crossref","unstructured":"Highly potent inhibitors of the Grb2-SH2 domain. Bioorg. Med. Chem. Lett, 9(2), 221\u2013226 | 10.1016\/s0960-894x(98)00701-x. Accessed: February. 21, 2025. https:\/\/doi.org\/10.1016\/S0960-894X(98)00701-X.","DOI":"10.1016\/S0960-894X(98)00701-X"},{"key":"10.1016\/j.bbrc.2025.151680_bib56","doi-asserted-by":"crossref","unstructured":"potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. J. Med. Chem., 42(1), 25\u201335 | 10.1021\/jm980388x. Accessed: February. 21, 2025. https:\/\/doi.org\/10.1021\/jm980388x.","DOI":"10.1021\/jm980388x"},{"issue":"4","key":"10.1016\/j.bbrc.2025.151680_bib57","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0006-291X(03)01291-9","article-title":"Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity","volume":"307","author":"Li","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25003948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25003948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:15:13Z","timestamp":1744096513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25003948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":57,"alternative-id":["S0006291X25003948"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151680","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel potent heterocyclic Grb2\u2013SH2 domain antagonists as potential anti-proliferative agents","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151680"}}